elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Pricing
Log in
Sign up
Home
/
Subjects
/
Cabozantinib
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Cabozantinib
RIS
0.001
(Research Intensity Score)
Papers
114
Top papers
Thyroid Cancer
2024 · 638 citations
Targeted therapy for hepatocellular carcinoma
2020 · 613 citations
Pheochromocytoma: an updated scoping review from clinical presentation to management and treatment
2024 · 35 citations
Molecular Biology of Osteosarcoma
2020 · 344 citations
Medication-induced osteonecrosis of the jaw: a review of cases from the Food and Drug Administration Adverse Event Reporting System (FAERS)
2023 · 59 citations
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
2019 · 335 citations
Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities
2022 · 55 citations
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
2018 · 448 citations
Emerging Diagnostics and Therapies in Neuroendocrine Neoplasms: A Critical Review
2025 · 6 citations
Newest papers
Redefining the Role of Chemotherapy and Targeted Cytotoxic Delivery in Lung Neuroendocrine Tumors
2026
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801)
2026
Targeted Therapies in Endocrine Malignancies
2026
Antineoplastic and Immunomodulatory Effects of Cabozantinib in Continuous and Primary Human Anaplastic Thyroid Cancer Cells
2026
A phase 2 randomized trial of radium-223 dichloride and cabozantinib in patients (pts) with renal cell carcinoma (RCC) with bone metastases (BM): RADICAL (Alliance A031801).
2026
Abstract 1486: From animals to computational oncology: Digital twins as ethical enablers of next-generation bone metastasis research
2026
Emerging Diagnostics and Therapies in Neuroendocrine Neoplasms: A Critical Review
2025 · 6 citations
Targeted therapy for liver cancer: Current status and future directions
2025 · 3 citations
Cabozantinib Sensitizes NSCLC Cells to Radiation by Inducing Ferroptosis via STAT3/MCL1/BECN1/SLC7A11 Axis Suppression
2025 · 4 citations
Browse all papers →
Cabozantinib's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Cabozantinib's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link